WHO prequalifies Biosimilar of Trastuzumab to provide cheaper breast cancer medicine

WHO allowed the commercial use of biosimilar drug of Trastuzumab to treat breast cancer.



from Jagran Josh https://ift.tt/35KgSSe

Post a Comment

0 Comments